Rhode Island Bill Removes Cannabis License Residency Requirement

Bill Text and Sponsorship

The bill removes the residency mandate currently embedded in Rhode Island's cannabis licensing statute. Under existing law, applicants for cultivation, manufacturing, and retail licenses must demonstrate Rhode Island residency. The new legislation strikes that provision entirely. Filed in the House of Representatives on May 22, 2026, according to the legislative record.

Sponsorship and committee assignment details weren't disclosed in available filings. The bill hasn't been scheduled for committee hearings yet.

Licensing Freeze Context

Rhode Island's Cannabis Control Commission suspended all new license applications in March 2026, citing operational capacity constraints. The agency announced the freeze in a public notice, stating it wouldn't accept new applications until further notice. No timeline for resumption has been published.

The freeze affects all license categories: cultivation, manufacturing, retail, and testing facilities. Existing licensees may continue operations and renewals. The suspension doesn't apply to medical marijuana establishments, which operate under a separate regulatory framework administered by the Department of Health.

Current Market Structure

Rhode Island issued its first adult-use retail licenses in December 2022, following voter approval of legalization in November 2022. The state operates a hybrid model: six incumbent medical dispensaries converted to dual-license status, while new adult-use-only retailers entered through a competitive application process. As of May 2026, the state has issued approximately 30 retail licenses, 15 cultivation licenses, and 8 manufacturing licenses, according to Cannabis Control Commission data.

The residency requirement has been a barrier to entry for multi-state operators. MSOs with operations in neighboring Massachusetts and Connecticut have lobbied for its removal since the adult-use market launched. For background on Rhode Island's licensing framework, see the CannIntel topic hub on Rhode Island Cannabis Licensing.

Interstate Implications

Eliminating the residency mandate would align Rhode Island with Massachusetts and Connecticut, neither of which impose residency requirements. Massachusetts removed its residency rule in 2017 after a legal challenge. Connecticut never adopted one. The alignment could accelerate consolidation in the New England market, where MSOs already operate vertically integrated operations across multiple states.

Rhode Island's small population—approximately 1.1 million residents—limits in-state capital pools. Industry analysts have noted that the residency requirement constrained the applicant pipeline, particularly for capital-intensive cultivation and manufacturing licenses.

Legislative Path Forward

The bill must clear committee review, floor votes in both chambers, and gubernatorial approval before taking effect. Rhode Island's General Assembly session runs through June 30, 2026. If the bill doesn't advance by that date, it'll carry over to the 2027 session.

Governor Daniel McKee hasn't commented publicly on the residency issue. His administration supported the original adult-use legalization measure in 2022, which included the residency provision as a compromise to secure legislative votes. Whether that political calculus has shifted remains unclear.

The next signal: whether the Cannabis Control Commission lifts its licensing freeze before or after the residency bill moves. If the freeze persists, the residency debate becomes academic until applications reopen.